Yoh Asahi, M.D., Ph.D. is a Global Scholar in Ajay Goel Lab.

Yuan Li is a lab member in Goel lab at City of Hope.

Alessandro Mannucci, M.D. graduated from San Raffaele University in Milan, Italy. During his university years, he researched hereditary syndromes that cause colorectal and endometrial cancer (including Lynch syndrome) at Dana-Farber Cancer Institute in Boston, MA. Upon receiving his M.D., he worked as a gastroenterology and endoscopy resident at San Raffaele Hospital in Milan, Italy. Dr. Mannucci's research focuses on hereditary cancer syndromes and mechanisms of early detection and prevention. At City of Hope, he hopes to understand the early events that lead to colon cancer development and immune evasion. Besides research, he enjoys mountaineering, reading, and traveling.

Katsuki Miyazaki, M.D., graduated from Tokushima University and worked as a general surgeon in Japan prior to joining City of Hope. Dr. Miyazaki has participated in research fields concerned with tumor immunity, nonalcoholic steatohepatitis and regenerative medicine in Japan. At City of Hope, Dr. Miyazaki’s goal is to research clinical biomarkers that can change the treatment and prognosis of gastrointestinal cancer, especially hepato-biliary-pancreatic cancer.
 

Keisuke Okuno, M.D., Ph.D., graduated from Tokyo Medical and Dental University and worked in Tokyo, Japan, as a gastric surgeon prior to joining City of Hope. He obtained his Ph.D. from Tokyo Medical and Dental University, and his Ph.D. research focused on the role of histone methylation in gastric cancer progression.
 
Dr. Okuno’s research interest is to elucidate the mechanism of cancer progression and find clinical biomarkers that can improve the prognosis of patients with gastrointestinal cancer. He is also interested in liquid biopsies that can easily diagnose cancer and predict the recurrence of cancer.
 
In addition to his research, he likes to play golf and travel with his family around Los Angeles.

Courtney Quan is a research associate and lab manager in Ajay Goel Lab.

Katsutoshi Shoda, M.D., Ph.D., graduated from Kyoto Prefectural University of Medicine in Kyoto, Japan, as a gastrointestinal surgeon at Yamanashi University before joining City of Hope. He obtained his Ph.D. from Kyoto Prefectural University of Medicine, and his research focused on the biomarkers relevant to treatment using liquid biopsies in gastric cancer. In addition to his research, he enjoys watching sports such as soccer and baseball and listening to soul music.

Silei Sui graduated from Dalian Medical University with a Ph.D. in oncology and worked on the molecular mechanism and clinical significance of colorectal cancer before joining City of Hope. After graduation, she worked as a visiting postdoctoral under the guidance of Ajay Goel, Ph.D., M.S., at City of Hope. She aims to identify clinical biomarkers for improving the survival and treatment effect of colorectal cancer based on a multi-omics NGS approach.

Sui is skilled in Python, R, and machine learning and experienced in the biological analysis of genome sequencing, transcriptional sequencing and single-cell sequencing data.

Outside of work, she enjoys fitness and listening to music.

Caiming Xu, M.D., Ph.D., worked as a visiting postdoctor under the guidance of Ajay Goel, Ph.D., M.S., at City of Hope. He obtained both his M.D. and Ph.D. in surgery at Dalian Medical University, Dalian, Liaoning, China. His Ph.D. research focuses on molecular mechanism of pancreatic ductal adenocarcinoma (PDAC) and acute pancreatitis. He revealed that the infiltration of immune cells may represent a possible target in the treatment of PDAC.
 
His research interest focuses on identifying novel biomarkers and targeting molecules for diagnosis and therapeutics of pancreatobiliary tumors using multi-omics NGS approach.
 
Outside of work, he enjoys football and ping-pong.